| tsRFun: a comprehensive platform for decoding human tsRNA expression, functions and prognostic value by high-throughput small RNA-Seq and CLIP-Seq data JH Wang, WX Chen, SQ Mei, YD Yang, JH Yang, LH Qu, LL Zheng Nucleic acids research 50 (D1), D421-D431, 2022 | 30 | 2022 |
| Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: a multi-institutional cohort study S Zhang, K Tang, G Wan, N Nguyen, C Lu, P Ugwu-Dike, N Raval, J Seo, ... Journal of the American Academy of Dermatology 88 (5), 1024-1032, 2023 | 17 | 2023 |
| Prediction of early-stage melanoma recurrence using clinical and histopathologic features G Wan, N Nguyen, F Liu, MS DeSimone, BW Leung, A Rajeh, MR Collier, ... NPJ precision oncology 6 (1), 79, 2022 | 17 | 2022 |
| Influence of melanoma type on incidence and downstream implications of cutaneous immune-related adverse events in the setting of immune checkpoint inhibitor therapy N Nguyen, G Wan, P Ugwu-Dike, NA Alexander, N Raval, S Zhang, ... Journal of the American Academy of Dermatology 88 (6), 1308-1316, 2023 | 9 | 2023 |
| Integrated analysis reveals the characteristics and effects of SARS-CoV-2 maternal–fetal transmission Z Huang, S Xia, S Mei, Y Wen, J Liu, C Dong, W Chen, P Yu, L Qu, Y Luo, ... Frontiers in Microbiology 13, 813187, 2022 | 8 | 2022 |
| Increased risk of cutaneous immune-related adverse events in patients treated with talimogene laherparepvec and immune checkpoint inhibitors: A multi-hospital cohort study BW Leung, G Wan, N Nguyen, H Rashdan, S Zhang, W Chen, S Cohen, ... Journal of the American Academy of Dermatology 88 (6), 1265-1270, 2023 | 2 | 2023 |
| Identification of cutaneous immune-related adverse events by International Classification of Diseases codes and medication administration W Chen, G Wan, N Nguyen, B Leung, J Wen, MR Collier, SG Kwatra, ... JAAD international 9, 112, 2022 | 2 | 2022 |
| Timing of cutaneous immune-related adverse events impacts survival in patients with cancer treated with immune-checkpoint inhibitors: A multi-institutional cohort study H Rashdan, S Zhang, G Wan, N Nguyen, K Roster, A Rajeh, K Tang, ... Journal of the American Academy of Dermatology, 2024 | | 2024 |
| 1241 Clusters of multi-organ toxicities are associated with improved survival among immune checkpoint inhibitor recipients: a population-level study W Chen, G Wan, K Roster, N Nguyen, A Rajesh, J Seo, H Rashdan, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| 1251 Seasonal and geographic patterns in cutaneous immune-related adverse events after treatment with immune checkpoint inhibitors: a multicenter analysis A Rajeh, K Roster, W Chen, G Wan, K Reynolds, NR Leboeuf, S Kwatra, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
